BMP SUNSTONE CP through its subsidiaries is a pharmaceutical marketing and distribution company that is building a proprietary portfolio of branded pharmaceutical and healthcare products in China and is pursuing partnerships with other companies seeking to enter the Chinese pharmaceutical market. It is the only U.S. public company to offer industry partners a comprehensive suite of market-entry services in China that includes pre-market entry analysis clinical trial management product registration market research as well as pharmaceutical marketing and distribution. BMP Sunstone\'s proprietary portfolio primarily focusing on women\'s health and pediatrics. The Company is headquartered in Plymouth Meeting Pennsylvania. BMP Sunstone Corp. has a market cap of $162.91 million; its shares were traded at around $3.92 with a P/E ratio of 56 and P/S ratio of 1.42.
Recent Trades of BMP Sunstone Corp. by Directors and Officers:
- Buy: Director John W Stakes bought 4,850 shares of BJGP stock on 06/17/2009 at the average price of $4.1; the price of the stock has decreased by 4.39% since.
Become a Premium Member to See This: (Free Trial):
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys:: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.
Rate This Article: |
  |